Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 94-32-6
2. Ethyl P-butylaminobenzoate
3. Ethyl 4-butylaminobenzoate
4. Benzoic Acid, 4-(butylamino)-, Ethyl Ester
5. 4-(butylamino)benzoic Acid Ethyl Ester
6. D68ep3v31w
7. 4-(n-butylamino)benzoic Acid Ethyl Ester
8. Ethyl 4-(butylamino)benzoate(4-(butylamino)benzoic Acid Ethyl Ester)
9. Unii-d68ep3v31w
10. Einecs 202-322-9
11. Ethyl P-(butylamino) Benzoate
12. Schembl5025348
13. Ethyl 4-(n-butylamino)benzoate
14. Ethyl-(4-n-butylamino)benzoate
15. Dtxsid1059101
16. Ethyl 4-(butylamino)benzoate #
17. Amy8838
18. Cs-m3379
19. Zinc1848484
20. Ethyl 4-(butylamino)benzoate, 98%
21. Mfcd00017283
22. Akos009048578
23. As-14744
24. Db-057490
25. Ft-0616833
26. A844918
27. W-109351
28. Q27276166
29. Ethyl 4-(butylamino)benzoate; Ethyl P-butylaminobenzoate
Molecular Weight | 221.29 g/mol |
---|---|
Molecular Formula | C13H19NO2 |
XLogP3 | 4.1 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 7 |
Exact Mass | 221.141578849 g/mol |
Monoisotopic Mass | 221.141578849 g/mol |
Topological Polar Surface Area | 38.3 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 198 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Ethyl 4-Butylamino-Benzoate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ethyl 4-Butylamino-Benzoate, including repackagers and relabelers. The FDA regulates Ethyl 4-Butylamino-Benzoate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ethyl 4-Butylamino-Benzoate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Ethyl 4-Butylamino-Benzoate supplier is an individual or a company that provides Ethyl 4-Butylamino-Benzoate active pharmaceutical ingredient (API) or Ethyl 4-Butylamino-Benzoate finished formulations upon request. The Ethyl 4-Butylamino-Benzoate suppliers may include Ethyl 4-Butylamino-Benzoate API manufacturers, exporters, distributors and traders.
click here to find a list of Ethyl 4-Butylamino-Benzoate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ethyl 4-Butylamino-Benzoate DMF (Drug Master File) is a document detailing the whole manufacturing process of Ethyl 4-Butylamino-Benzoate active pharmaceutical ingredient (API) in detail. Different forms of Ethyl 4-Butylamino-Benzoate DMFs exist exist since differing nations have different regulations, such as Ethyl 4-Butylamino-Benzoate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ethyl 4-Butylamino-Benzoate DMF submitted to regulatory agencies in the US is known as a USDMF. Ethyl 4-Butylamino-Benzoate USDMF includes data on Ethyl 4-Butylamino-Benzoate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ethyl 4-Butylamino-Benzoate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ethyl 4-Butylamino-Benzoate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ethyl 4-Butylamino-Benzoate Drug Master File in Japan (Ethyl 4-Butylamino-Benzoate JDMF) empowers Ethyl 4-Butylamino-Benzoate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ethyl 4-Butylamino-Benzoate JDMF during the approval evaluation for pharmaceutical products. At the time of Ethyl 4-Butylamino-Benzoate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ethyl 4-Butylamino-Benzoate suppliers with JDMF on PharmaCompass.
Ethyl 4-Butylamino-Benzoate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ethyl 4-Butylamino-Benzoate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ethyl 4-Butylamino-Benzoate GMP manufacturer or Ethyl 4-Butylamino-Benzoate GMP API supplier for your needs.
A Ethyl 4-Butylamino-Benzoate CoA (Certificate of Analysis) is a formal document that attests to Ethyl 4-Butylamino-Benzoate's compliance with Ethyl 4-Butylamino-Benzoate specifications and serves as a tool for batch-level quality control.
Ethyl 4-Butylamino-Benzoate CoA mostly includes findings from lab analyses of a specific batch. For each Ethyl 4-Butylamino-Benzoate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ethyl 4-Butylamino-Benzoate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ethyl 4-Butylamino-Benzoate EP), Ethyl 4-Butylamino-Benzoate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ethyl 4-Butylamino-Benzoate USP).
LOOKING FOR A SUPPLIER?